Skip to main content
. 2020 Sep 24;8(10):3371–3377.e1. doi: 10.1016/j.jaip.2020.09.015

Table I.

Patients' demographic characteristics

Characteristic White (n = 845) Minority (n = 118) P value
Age (y), mean ± SD 26.0 ± 12.4 20.2 ± 12.6 <.001
Sex: female 88.0 (743) 70.3 (83) <.001
Household income ($) <.001
 $25,000 7.3 (60) 20.5 (23)
 25,000-49,999 15.9 (130) 25.9 (29)
 50,000-$74,999 16.2 (132) 12.5 (14)
 75,000-99,999 17.7 (145) 14.3 (16)
 100,000+ 42.8 (350) 26.8 (30)
Currently live <.001
 Urban 19.7 (166) 38.1 (45)
 Peri-urban/suburban 56.7 (477) 50.8 (60)
 Rural 23.6 (199) 11.0 (13)
Comorbidities
 Heart disease 3.9 (32) 3.6 (4) .869
 Hypertension 21.1 (174) 24.5 (27) .415
 Depression 38.4 (313) 35.7 (40) .582
 GERD 41.3 (339) 33.3 (38) .102
 Diabetes 6.6 (53) 5.5 (6) .645
 Seasonal allergies 88.1 (734) 85.3 (99) .393
Have a PCP 94.4 (798) 89.0 (105) .022
Have asthma specialist 37.0 (313) 30.5 (36) .167
Age at asthma diagnosis (y), mean ± SD 20.8 ± 15.1 16.8 ± 13.8 .006
Asthma ED in past year 25.3 (213) 35.0 (41) .025
ICU or intubation ever for asthma 6.0 (51) 16.1 (19) <.001
Asthma severity .122
 Mild 44.2 (373) 39.0 (46)
 Moderate 45.0 (380) 44.9 (53)
 Severe 8.1 (68) 14.4 (17)
 Not sure 2.7 (23) 1.7 (2)
Current asthma medications
 Albuterol 93.6 (791) 93.2 (110) .872
 Montelukast 34.8 (294) 27.1 (32) .099
 ICS 24.7 (209) 23.7 (28) .812
 ICS w/LABA 41.9 (354) 36.4 (43) .26
 Oral steroids 4.7 (40) 9.3 (11) .037
 Biologics 3.6 (30) 5.1 (6) .41
ACT score, mean ± SD 18.5 ± 4.8 17.4 ± 4.8 .018
ACT uncontrolled (score ≤ 19) 47.9 (404) 59.0 (69) .024

ED, Emergency department; GERD, gastroesophageal reflux disease; ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; PCP, primary care physician.

Data presented as % (n) unless otherwise noted. Bold indicates statistical significance (P < .05).